A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension
| Autor: | Smith, D.H.G., Neutel, J.M., Jankelow, D., Pretorius, J.J.L., Myburgh, D.P. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Zdroj: | South African Medical Journal; Vol 79, No 1 (1991); 12-15 |
| ISSN: | 2078-5135 0256-9574 |
| Popis: | The antihypertensive effects, as assessed by clinical and ambulatory blood pressure measurement, of nifedipine slowrelease (SR), atenolol and the two In combination were evaluated In 28 known hypertenslv88 In a placebo-controlled, double-blind, randomlsed cross-over trial. Clinical blood pressure was significantly lower on combination therapy (P< 0,025) than on either agent alone, although all therapeutic agents reduced blood pressure significantly when compared with placebo (P< 0,01). All ambulatory blood pressure measurements obtained on any therapeutic agent were significantly lower than those obtained on placebo (P < 0,01). The mean daytime (08h00 17h00) ambulatory blood pressure measurement as well as the percentage of this monitoring period dUring which patients were hypertensive were significantly lower (P < 0,01) on combination therapy than on nifedipine SR. A similar pattern was observed for 24-hour ambulatory blood pressure measurements. Headache was the most significant adverse effect. This was most common with nHedlplne SR, less common with combination therapy and least common with atenolol. Combination therapy with nifedipine SR and atenolol is therefore a viable therapeutic alternative in the treatment of patients with benign essential hypertension. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|